Ticks and Tularemia: Do We Know What We Don't Know?

被引:47
|
作者
Zellner, Briana [1 ]
Huntley, Jason F. [1 ]
机构
[1] Univ Toledo, Coll Med & Life Sci, Dept Med Microbiol & Immunol, 2801 W Bancroft St, Toledo, OH 43606 USA
关键词
tularemia; tick; Francisella tularensis; vector-borne disease; Dermacentor; Amblyomma; IXODES-RICINUS TICKS; FRANCISELLA-LIKE ENDOSYMBIONTS; DERMACENTOR-VARIABILIS; MOLECULAR EPIDEMIOLOGY; BORRELIA-BURGDORFERI; ACARI IXODIDAE; WOOD TICK; TULARENSIS; ANDERSONI; PREVALENCE;
D O I
10.3389/fcimb.2019.00146
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Francisella tularensis, the causative agent of the zoonotic disease tularemia, is characterized by high morbidity and mortality rates in over 190 different mammalian species, including humans. Based on its low infectious dose, multiple routes of infection, and ability to induce rapid and lethal disease, F. tularensis has been recognized as a severe public health threat-being designated as a NIH Category A Priority Pathogen and a CDC Tier 1 Select Agent. Despite concerns over its use as a bioweapon, most U.S. tularemia cases are tick-mediated and ticks are believed to be the major environmental reservoir for F. tularensis in the U.S. The American dog tick (Dermacentor variabilis) has been reported to be the primary tick vector for F. tularensis, but the lone star tick (Amblyomma americanum) and other tick species also have been shown to harbor F. tularensis. This review highlights what is known, not known, and is debated, about the roles of different tick species as environmental reservoirs and transmission vectors for a variety of F. tularensis genotypes/strains.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] What do we know about density functional construction, and what don't we know?
    Perdew, John P.
    Ruzsinszky, Adrienn
    Csonka, Gabor I.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [22] What don't we know, and when did we know that we didn't know it?
    LeBoit, Philip E.
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2006, 28 (01) : 89 - 90
  • [23] A Retrospective on the SiGe HBT: What We Do Know, What We Don't Know, and What We Would Like to Know Better
    Cressler, John D.
    2013 IEEE 13TH TOPICAL MEETING ON SILICON MONOLITHIC INTEGRATED CIRCUITS IN RF SYSTEMS (SIRF), 2013, : 81 - 83
  • [24] Digital mammography: what do we and what don't we know?
    Bick, Ulrich
    Diekmann, Felix
    EUROPEAN RADIOLOGY, 2007, 17 (08) : 1931 - 1942
  • [25] Digital mammography: what do we and what don’t we know?
    Ulrich Bick
    Felix Diekmann
    European Radiology, 2007, 17 : 1931 - 1942
  • [26] "Tau oligomers," what we know and what we don't know
    Sahara, Naruhiko
    Avila, Jesus
    FRONTIERS IN NEUROLOGY, 2014, 5
  • [27] Fulleride superconductors: What we know and what we don't know
    Fischer, JE
    CHEMICAL PHYSICS OF FULLERENES 10 (AND 5) YEARS LATER: THE FAR-REACHING IMPACT OF THE DISCOVERY OF C60, 1996, 316 : 359 - 382
  • [28] Metabolic syndrome - What we know and what we don't know
    Ritz, Eberhard
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 18 (06): : 1619 - 1623
  • [29] UK Beef Lameness; what we know, what we don't know and where do we go?
    Floyd, T.
    CATTLE PRACTICE, 2023, 31 (01) : 97 - 97
  • [30] Corporate governance: what we know and what we don't know
    Elston, Julie
    JOURNAL OF INDUSTRIAL AND BUSINESS ECONOMICS, 2019, 46 (02): : 147 - 156